Adult T-Cell Leukemia/lymphoma has active NIH research funding with 17 funded grants totaling $18.1M.
2 new grants started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Adult T-Cell Leukemia/lymphoma. Strongest funded area: Basic Science. Largest gap: Clinical Research.
19 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for adult T-cell leukemia/lymphoma. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Adult T-Cell Leukemia/lymphoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Adult T-Cell Leukemia/lymphoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.